RIDAURA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ridaura, and what generic alternatives are available?
Ridaura is a drug marketed by Sebela Ireland Ltd and is included in one NDA.
The generic ingredient in RIDAURA is auranofin. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the auranofin profile page.
Summary for RIDAURA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Clinical Trials: | 7 |
Patent Applications: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for RIDAURA |
What excipients (inactive ingredients) are in RIDAURA? | RIDAURA excipients list |
DailyMed Link: | RIDAURA at DailyMed |
Recent Clinical Trials for RIDAURA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 2 |
National Cancer Institute (NCI) | Phase 2 |
National Cancer Institute (NCI) | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for RIDAURA
US Patents and Regulatory Information for RIDAURA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RIDAURA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RIDAURA
See the table below for patents covering RIDAURA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | A352973 | ⤷ Try a Trial | |
Japan | S4919014 | ⤷ Try a Trial | |
Finland | 53067 | ⤷ Try a Trial | |
Hungary | 171209 | SPOSOB POLUCHENIJA AEROZOLIJJ SODERZHAHHIKH STEROIDOV S EFFEKTOM PROTIV VOSPLAMENENIJA (PROCESS FOR PRODUCING AEROSOLE COMPOSITIONS CONTAINING STEROIDES OF ANTIINFLAMMATORIC ACTIVITY) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |